Drug diversion administrative revocation and application hearings for medical and pharmacy practitioners: a primer for navigating murky, drug-infested waters.

The prevalence of prescription controlled substance abuse has grown exponentially over the past decade.1 State and federal regulatory agencies have struggled to adjust to the changing realities of a new challenge and a new dynamic between the regulators and the regulated community. State boards and federal regulators that have operated for decades on well-founded principles of mutual collegiality have been forced to revisit old